202 related articles for article (PubMed ID: 16982965)
1. Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade.
Barker TA; Massett MP; Korshunov VA; Mohan AM; Kennedy AJ; Berk BC
Hypertension; 2006 Nov; 48(5):942-9. PubMed ID: 16982965
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP.
Siragy HM; de Gasparo M; El-Kersh M; Carey RM
Hypertension; 2001 Aug; 38(2):183-6. PubMed ID: 11509473
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
[TBL] [Abstract][Full Text] [Related]
4. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.
Savoia C; Ebrahimian T; He Y; Gratton JP; Schiffrin EL; Touyz RM
J Hypertens; 2006 Dec; 24(12):2417-22. PubMed ID: 17082724
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.
Cao Z; Kelly DJ; Cox A; Casley D; Forbes JM; Martinello P; Dean R; Gilbert RE; Cooper ME
Kidney Int; 2000 Dec; 58(6):2437-51. PubMed ID: 11115077
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
Koid SS; Ziogas J; Campbell DJ
Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
[TBL] [Abstract][Full Text] [Related]
8. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits.
Li J; Hirose N; Kawamura M; Arai Y
Atherosclerosis; 1999 Apr; 143(2):315-26. PubMed ID: 10217360
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress.
Yagi S; Morita T; Katayama S
Hypertens Res; 2004 Feb; 27(2):129-35. PubMed ID: 15005276
[TBL] [Abstract][Full Text] [Related]
10. Effects of the combined use of benazepril and valsartan on apoptosis in the kidney of rats with adriamycin-induced nephritic glomerulosclerosis.
Han Z; Xing Y; Wang H; Liang X; Zhou J
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):254-8. PubMed ID: 15315341
[TBL] [Abstract][Full Text] [Related]
11. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
12. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Endlich K; Steinhausen M
J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
[TBL] [Abstract][Full Text] [Related]
13. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
Campbell R; Sangalli F; Perticucci E; Aros C; Viscarra C; Perna A; Remuzzi A; Bertocchi F; Fagiani L; Remuzzi G; Ruggenenti P
Kidney Int; 2003 Mar; 63(3):1094-103. PubMed ID: 12631093
[TBL] [Abstract][Full Text] [Related]
14. Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.
Jacobsen P; Andersen S; Jensen BR; Parving HH
J Am Soc Nephrol; 2003 Apr; 14(4):992-9. PubMed ID: 12660333
[TBL] [Abstract][Full Text] [Related]
15. Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose tolerance.
Chow L; De Gasparo M; Levens N
Eur J Pharmacol; 1997 Jan; 319(1):77-83. PubMed ID: 9030901
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
17. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
Chow L; De Gasparo M; Levens N
Eur J Pharmacol; 1995 Aug; 282(1-3):77-86. PubMed ID: 7498292
[TBL] [Abstract][Full Text] [Related]
18. [Effects of benazepril combined with valsartan on congestive heart failure].
Ye JF; Liu DS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1441-2, 1447. PubMed ID: 16305977
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Brouwers S; Smolders I; Massie A; Dupont AG
Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
[TBL] [Abstract][Full Text] [Related]
20. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
Ke YS; Cao H; Yang T
Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
